We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+14.4%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$1.62B
AUM Growth
+$77.5M
Cap. Flow
-$61.1M
Cap. Flow %
-3.78%
Top 10 Hldgs %
28.88%
Holding
1,192
New
187
Increased
321
Reduced
580
Closed
103

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$3.14M
2
AVGO icon
Broadcom
AVGO
+$3.01M
3
TSLA icon
Tesla
TSLA
+$2.23M
4
TWST icon
Twist Bioscience
TWST
+$1.76M
5
NVAX icon
Novavax
NVAX
+$1.74M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$26.2M
2
DHR icon
Danaher
DHR
+$17.1M
3
AMGN icon
Amgen
AMGN
+$12.4M
4
GILD icon
Gilead Sciences
GILD
+$9.52M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$7.11M

Sector Composition

Rank Sector Weight
1 Technology 33.28%
2 Healthcare 16.86%
3 Consumer Discretionary 11.45%
4 Communication Services 8.63%
5 Energy 7.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IQ icon
326
iQIYI
IQ
$1.2B
$896K 0.06%
123,111
+4,295
+4% +$29.5K
CCI icon
327
Crown Castle
CCI
$32.7B
$893K 0.06%
6,673
-2,052
-24% -$284K
AGIO icon
328
Agios Pharmaceuticals
AGIO
$2.25B
$885K 0.05%
+38,524
New +$1.02M
ETNB
329
DELISTED
89bio
ETNB
$884K 0.05%
+58,076
New +$757K
RNAM
330
DELISTED
Avidity Biosciences
RNAM
$881K 0.05%
+57,365
New +$1.26M
TTE icon
331
TotalEnergies
TTE
$188B
$879K 0.05%
14,882
+1,136
+8% +$69.9K
CTIC
332
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$876K 0.05%
+208,517
New +$1.08M
BUD icon
333
AB InBev
BUD
$156B
$871K 0.05%
13,050
+996
+8% +$60.2K
HSBC icon
334
HSBC
HSBC
$354B
$867K 0.05%
25,414
+1,940
+8% +$69.6K
SE icon
335
Sea Limited
SE
$64B
$866K 0.05%
10,005
-1,285
-11% -$87.7K
KYNB
336
Kyntra Bio
KYNB
$28.8M
$865K 0.05%
+1,855
New +$981K
DD icon
337
DuPont de Nemours
DD
$18.6B
$865K 0.05%
9,603
-1,916
-17% -$175K
CHX
338
DELISTED
ChampionX
CHX
$861K 0.05%
31,753
-9,190
-22% -$275K
GM icon
339
General Motors
GM
$77.2B
$860K 0.05%
23,439
+6,600
+39% +$250K
HCA icon
340
HCA Healthcare
HCA
$86.1B
$856K 0.05%
3,247
-229
-7% -$58.2K
SEDG icon
341
SolarEdge
SEDG
$2.52B
$853K 0.05%
2,808
+695
+33% +$212K
HTHT icon
342
Huazhu Hotels Group
HTHT
$12.9B
$853K 0.05%
17,416
-11,306
-39% -$548K
UMC icon
343
United Microelectronic
UMC
$47B
$851K 0.05%
97,158
-25,862
-21% -$210K
MYGN icon
344
Myriad Genetics
MYGN
$527M
$846K 0.05%
+36,397
New +$739K
CNP icon
345
CenterPoint Energy
CNP
$28.7B
$842K 0.05%
28,592
-1,609
-5% -$47K
BBIO icon
346
BridgeBio Pharma
BBIO
$16.6B
$842K 0.05%
+50,773
New +$592K
PBR icon
347
Petrobras
PBR
$117B
$839K 0.05%
80,465
-2,941
-4% -$32K
VRDN icon
348
Viridian Therapeutics
VRDN
$2.2B
$837K 0.05%
+32,900
New +$1.05M
TER icon
349
Teradyne
TER
$51.4B
$837K 0.05%
7,783
+1,772
+29% +$181K
CL icon
350
Colgate-Palmolive
CL
$73.3B
$834K 0.05%
11,093
+1,897
+21% +$141K
12 13
14
15 16

Similar funds

MASUI
MIRAE ASSET SECURITIES (USA) INC. New York $2.72B AUM 36.56% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
MSL
Mackay Shields LLC New York $2.73B AUM 2.13% 1-Year Est. Return
CA
Cornerstone Advisors Asheville, North Carolina $2.72B AUM 22.17% 1-Year Est. Return
TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return
FNF
Fidelity National Financial Jacksonville, Florida $2.72B AUM 29.3% 1-Year Est. Return

Profund Advisors's Q1 2023 Portfolio in Review

As of Q1 2023, Profund Advisors held 1,192 positions worth $1.62B, up 5% from $1.54B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Profund Advisors withdrew a net $61.1M in Q1 2023, closing 103 positions and reducing 580 holdings. Its most notable exit was Cheniere Energy, an estimated $2.09M position sold in full.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Profund Advisors opened a new position in Twist Bioscience worth $1.2M.

  • Profund Advisors's largest Q1 2023 buy was Twist Bioscience: 79,459 shares worth $1.2M.
  • Profund Advisors added most to NVIDIA in Q1 2023, an estimated $3.14M increase.
  • Profund Advisors's biggest Q1 2023 reduction was AbbVie, cutting an estimated $26.2M.
  • Profund Advisors fully exited Cheniere Energy in Q1 2023, selling an estimated $2.09M.
  • Profund Advisors's ten largest holdings make up 29% of its $1.62B portfolio in Q1 2023.
  • Profund Advisors opened 187 new positions and closed 103 in Q1 2023.
  • Profund Advisors's portfolio value rose 5% quarter-over-quarter to $1.62B.

Based on Profund Advisors's 13F filing for Q1 2023, filed 12 May 2023.